Virtual oncology involves the use of digital technologies and computers to simulate clinical scenarios in oncology. Virtual oncology solutions help physicians plan treatments, visualize anatomical structures, simulate surgical procedures and radiation therapies. These solutions provide accurate 3D reconstructions of tumors and surrounding tissues based on medical scans. This helps physicians evaluate different treatment strategies and their potential impact on cancer patients in a safe, virtual environment before actual treatment.
The global virtual oncology Market is estimated to be valued at US$ 3.94 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The opportunity for improved cancer patient outcomes through personalized treatment planning is driving growth of the virtual oncology market. Virtual oncology solutions enable physicians to simulate various treatment options tailored to an individual patient's anatomy and tumor characteristics. This helps identify the treatment approach with the highest chance of success while minimizing risks of complications or side effects. With growing clinical evidence demonstrating benefits of personalized treatment planning using virtual oncology, its adoption is increasing among healthcare providers. As virtual oncology can potentially improve survival rates and quality of life for cancer patients through optimized treatment protocols customized for each patient, the market is expected to witness significant demand over the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the virtual oncology market is medium as the market requires significant investment to set up infrastructure and develop virtual technologies and solutions. However, the threat may increase over the forecast years with reducing entry barriers.
Bargaining power of buyers: The bargaining power of buyers is high in the virtual oncology market as the market has several existing players providing virtual solutions. This gives power to buyers to negotiate on price and quality of service.
Bargaining power of suppliers: The bargaining power of suppliers is medium as the suppliers of virtual technologies have to compete with several other suppliers. However, as virtual oncology requires specialized skills and technologies, the suppliers enjoy moderate bargaining power.
Threat of new substitutes: The threat of substitutes is low as there are limited substitutes available for virtual oncology solutions. New technologies may pose potential threat over the long term.
Competitive rivalry: The competitive rivalry is high due to presence of numerous regional and international players providing similar virtual oncology solutions.
SWOT Analysis
Strengths: Virtual oncology provides cost-effective treatment planning and radiation delivery. It offers precise 3D views of tumors allowing for customized treatment options.
Weaknesses: High initial investment requirements for setting up virtual infrastructures. Lack of skilled oncologists familiar with virtual technologies in developing nations.
Opportunities: Growing prevalence of cancer worldwide presenting scope for adoption of virtual oncology. Emerging economies provide lucrative growth prospects.
Threats: Switching costs associated with existing conventional treatment methods act as a barrier. Concerns regarding data privacy and security issues related to cloud-based virtual solutions.
Key Takeaways
The global Virtual Oncology Market Share is expected to witness high growth over the forecast period of 2024 to 2031. The global virtual oncology Market is estimated to be valued at US$ 3.94 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031.
Regionally, North America is expected to dominate the global virtual oncology market during the forecast period. Factors such as growing cancer prevalence, availability of advanced healthcare facilities, and presence of major players in the region will help drive the market. The Asia Pacific region is expected to grow at the fastest pace during the forecast period attributed to large patient pool, increasing healthcare expenditure, and development of healthcare infrastructure.
Key players operating in the virtual oncology market are KTK, Shanghai Electric, Westinghouse, Jiacheng, Kangni, Horton Automatics, Nabtesco, Stanley, Fangda, Faiveley, Manusa, Panasonic. Major players are focusing on new product launches, partnerships, and mergers & acquisitions to expand their global presence.
For more insights, read- https://www.ukwebwire.com/virtual-oncology-market-trends-size-and-share-analysis/
For more details on the report, Read- https://cmiinfopiece.blogspot.com/2024/01/the-global-immunology-market-growth.html
This report aims to provide detailed insights into the global interventional oncology market.
It provides valuable information on the type, procedure, application, and region in the market.
Furthermore, the information for these segments, by region, is also presented in this report.
Don't miss out on business opportunities in Interventional Oncology Market Revenue Growth Analysis: [215 Pages Report] The global interventional oncology market size is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2020, at a CAGR of 6.8% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164 Key Factors Driving Market Growth: The global interventional oncology market offers significant growth potential for prominent as well as emerging product manufacturers.
Technological advancements, rising incidence of oncology and increased funding and public-private investments are some of the key factors driving the growth of the market.
Although these devices are primarily employed to treat hepatocellular carcinoma, their use has been widely extended to various other forms of cancer.
